Taiwan develops new ways to effectively combat HIV

Taiwanese researchers have successfully developed a new way to combat HIV effectively using compounds, which have been published on the latest website of the Proceedings of the National Academy of SciencesThis is Taiwan's first AIDS vaccine and the first AIDS vaccine in the world based on seone, Taiwan's Union Evening News reportedIf successful, it can be given to normal people to prevent AIDSBut only animal trials have been completed, and the true clinical success is still far from thatXu Cuiling, a postdoctoral researcher at Taiwan's Institute of Chinese Studies' Genetic Research Center, who participated in the study, said THAT HIV is a difficult target, and that the global medical science community already has more than a dozen vaccines to prevent HIV by improving immunity, but they have failed in clinical trials, and their research results may open another window of hope for future AIDS preventionXu Said that the research team designed the invention of the compound called "tree sudden", it has two roles, one is to block HIV and avoid infection, the other is as a vaccine, inoculated into the normal human body, once accidentally infected in the future, will not become illClearly, being used as a vaccine is the ultimate function of this compoundShe explained that THE structure of HIV appears to have the chemical structure of the sac, and the structure of the "dendrite" is very similar to these structures, it will be into the body, will produce an HIV antibody response, which in turn produces an immune response in the body, to achieve protective effectTaiwan's "Director of Chinese Research" Ong Qihui said the team has successfully used this method in laboratory mice to produce antibodies against the hiv surface of the argon protein, in addition, the experimental data also showed that the surface of HIV's sein, has lost the ability to infect immune cellsXu said recently scientists have found that some people in Austria who are infected with HIV but do not develop the disease have an antibody called "2G12" in their bodies that attack HIV against hivThey provide scientists with an opportunity for research and developmentHowever, Wang Shengkai, a graduate student at the ScrippS Institute in the United States, points out that only a few hiv-infected patients start the immune mechanism in the body; so their team delved into the effects of the antibody and found that the antibody would identify the saccharine block on the surface of the HIV surface, and then find the new compound of "tree-protrusion"Xu Cuiling pointed out that after the completion of animal experiments in mice, they will work towardhuman trials to confirm that the dendritic ferns are a vaccine against HIV andhealthfor humansBut she stressed that the road is long and arduous, and that even if all goes well, it will be years before the drug and vaccine products come out